
Neovasc NVCN
Annual report 2021
added 12-23-2023
Neovasc DIO Ratio 2011-2026 | NVCN
Annual DIO Ratio Neovasc
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 10.1 | 31.5 | 17.2 | 21.1 | 14.9 | 33.9 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 33.9 | 10.1 | 21.5 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | ||
|
Alphatec Holdings
ATEC
|
271 | $ 14.04 | 0.79 % | $ 2.11 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | ||
|
ClearPoint Neuro
CLPT
|
220 | $ 15.16 | 4.19 % | $ 410 M | ||
|
Cognyte Software Ltd.
CGNT
|
76.7 | $ 6.62 | 3.6 % | $ 475 M | ||
|
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | ||
|
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M | ||
|
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | ||
|
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | ||
|
AxoGen
AXGN
|
238 | $ 31.22 | -3.94 % | $ 1.44 B | ||
|
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
163 | $ 4.59 | 2.68 % | $ 171 M | ||
|
Aziyo Biologics
AZYO
|
108 | - | 1.37 % | $ 20.5 M | ||
|
Apyx Medical Corporation
APYX
|
213 | $ 3.42 | -3.39 % | $ 118 M | ||
|
Conformis
CFMS
|
160 | - | - | $ 16.4 M | ||
|
Electromed
ELMD
|
91.2 | $ 23.92 | 3.33 % | $ 202 M | ||
|
Bio-Rad Laboratories
BIO
|
237 | $ 269.65 | 0.29 % | $ 7.61 B | ||
|
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | ||
|
Bruker Corporation
BRKR
|
216 | $ 39.89 | 0.3 % | $ 5.94 K | ||
|
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
169 | $ 73.48 | -2.22 % | $ 109 B | ||
|
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | ||
|
IRadimed Corporation
IRMD
|
251 | $ 100.5 | 1.42 % | $ 1.27 B | ||
|
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | ||
|
CONMED Corporation
CNMD
|
205 | $ 45.98 | -0.17 % | $ 1.43 B | ||
|
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | ||
|
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | ||
|
LivaNova PLC
LIVN
|
127 | $ 70.29 | 1.8 % | $ 3.83 B | ||
|
InMode Ltd.
INMD
|
307 | $ 13.96 | -0.14 % | $ 902 M | ||
|
Pulmonx Corporation
LUNG
|
282 | $ 1.63 | 7.95 % | $ 63.8 M | ||
|
Cutera
CUTR
|
135 | - | -10.19 % | $ 1.99 M | ||
|
Medtronic PLC
MDT
|
168 | $ 96.65 | -0.1 % | $ 124 B | ||
|
MiMedx Group
MDXG
|
123 | $ 5.28 | -1.31 % | $ 780 M | ||
|
Delcath Systems
DCTH
|
302 | $ 10.21 | 2.61 % | $ 291 M | ||
|
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | ||
|
Dynatronics Corporation
DYNT
|
91.1 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
85.3 | - | - | $ 10.2 M | ||
|
Myomo
MYO
|
76 | $ 0.75 | 16.11 % | $ 5.29 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.45 | 0.82 % | $ 144 M | ||
|
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | ||
|
Establishment Labs Holdings
ESTA
|
511 | $ 78.29 | -1.73 % | $ 2.2 B | ||
|
Insulet Corporation
PODD
|
210 | $ 248.12 | 1.17 % | $ 17.5 B | ||
|
Quanterix Corporation
QTRX
|
138 | $ 6.29 | 10.35 % | $ 236 M | ||
|
GBS
GBS
|
143 | - | -0.57 % | $ 7.12 M |